The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. The Cambridge, England-based biopharmaceutical company ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.
In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...